ReviewInflammopharmacology2026
Protective effects of antidepressants against ulcerogenic agents: insights from nonclinical studies.
Review in Inflammopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Influence of fluoxetine on the gastric healing process: experimental evidence of sexual dimorphism.Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThere is a marked overlap among the neuronal pathogenetic pathways involved in ulcer genesis and depression, and antidepressants can also exert a protective effect against gastric ulcers.
objectiveTo summarize and critically discuss non-clinical evidence about the gastroprotective potential of antidepressants. METHODOLOGY: Articles related to the survey were searched on PubMed, ScienceDirect, MedLine, and Lilacs, identifying 163 publications from 1974 to 2024, after reviewing 27 articles were selected.
resultsAll experimental research on the antiulcer potential of antidepressants has used acute gastric ulcer models, mainly ethanol- and indomethacin- induced ulcers. Tricyclic antidepressants, such as amitriptyline, are the most researched and have shown significant gastroprotective effects, reducing ulcer size and severity, and inhibiting NOX2 and NOX4 (enzymes from the NADPH oxidase family) expression in gastric mucosa. Selective serotonin reuptake inhibitors also exhibit gastroprotective effects. Fluoxetine decreased ulcer size in a stress and indomethacin model while increasing antioxidant production and decreasing inflammation in indomethacin-induced ulcers, but one study found that fluoxetine had a greater gastroprotective effect in male rodents than in females, highlighting the need for further research on sex differences. Mirtazapine and duloxetine have also shown gastroprotective benefits. Mirtazapine reduced ulcer size in an indomethacin model. In a stress and indomethacin model, duloxetine reduced ulcer size while also decreasing NOX1 and NOX4 expression. The mechanisms underlying the gastroprotective effects of antidepressants involve peripheral reduction of mucosal oxidative stress and central modulation of vagal stimulus and an increase in noradrenergic and serotonergic neurotransmission.
conclusionsOverall, the trials examined show that antidepressants are effective in preventing ulcers and may be useful in protecting against gastric ulcer development, especially in people with depression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.